Bladder cancer drug alpha1-oleate disrupts adipokine-driven tumor metabolism
Intravesical alpha1-oleate treatment strongly suppressed glucose- and lipid-metabolism genes and altered adiponectin and leptin signaling in bladder tumor tissue compared ...
